SVB collapse is double-whammy for tech startups currently navigating brutal marketplace

SVB collapse is double-whammy for tech startups currently navigating brutal marketplace


Critical Details
  • Startup CEOs across the U.S. had been now chopping charges and preserving hard cash in advance of Silicon Valley Bank’s failure made additional head aches.
  • Exit exercise for enterprise-backed startups in the fourth quarter plunged more than 90% from a calendar year earlier, in accordance to facts from the PitchBook-NVCA Undertaking Monitor.
  • “There was just a complete reversal of the pace at which buyers have been keen to move,” claimed ChartHop CEO Ian White.



Supply

China didn’t grab many headlines at Davos, but it’s the elephant in the room
Finance

China didn’t grab many headlines at Davos, but it’s the elephant in the room

Davos 2026 China didn’t grab many headlines at Davos, but it’s the elephant in the room Published Sun, Jan 25 20267:04 PM ESTUpdated 56 Min Ago Evelyn Cheng@in/evelyn-cheng-53b23624@chengevelyn WATCH LIVE Source

Read More
Energy stocks to watch as major winter storm rips through the U.S.
Finance

Energy stocks to watch as major winter storm rips through the U.S.

Winter storm Fern is projected to have a wide-ranging impact on energy and power production. Here are a few stocks and energy related industry groups to watch around this and future storms. Natural gas producers The price move in natural gas has been profound. A 70% jump in the commodity in fewer than two weeks is stuff […]

Read More
Stocks making the biggest moves midday: Fortinet, Moderna, Intel, Bausch Health & more
Finance

Stocks making the biggest moves midday: Fortinet, Moderna, Intel, Bausch Health & more

Check out the companies making headlines in midday trading. Fortinet — Shares jumped more than 7% after TD Cowen upgraded the cybersecurity stock to buy from hold, saying rising memory prices won’t hurt the company as much as some suspect. The firm’s $100 price target suggests 29% upside ahead. Bausch Health — The pharmaceutical stock […]

Read More